About: Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.76 (+3.16%)
WVE NASDAQ Wave Life Sciences Ltd
Wave Life Sciences Ltd share price
Atividade de preço de WVE
Último preço
$ 3,760
Variação (24h)
0,12 USD (3,16%)
Volume
1.15M
Volume (média 4 sem.)
-
Abertura
$ 3,75
Variação do dia
$ 3,66 - $ 3,86
Fechamento anterior
$ 3,64
Último negócio
29 Oct, 2:54 pm GMT+0
Atrasado
29 Oct, 2:54 pm GMT+0
WVE price performance
Atrasado
29 Oct, 2:54 pm GMT+0
quote.marketSignals